M MEDEVA
associated with 6 other trademarks
Vaccines for use in the prevention and treatment of influenza, typhoid, tetanus, pertussis, tuberculosis, cholera, rubella, yellow fever, hepatitis, p...

Words that describe this trademark:

prevention treatment  tetanus pertussis  vaccines prevention  treatment influenza  cholera  influenza  rubella  pertussis  typhoid  tuberculosis 

Serial Number:

75485854

Mark:

M MEDEVA

Status:

Cancelled-Section 8

Status Date:

05-23-2009

Filing Date:

Registration Number:

2633749

Registration Date:

10-15-2002

Goods and Services:

Vaccines for use in the prevention and treatment of influenza, typhoid, tetanus, pertussis, tuberculosis, cholera, rubella, yellow fever, hepatitis, polio, diphtheria, neisseria, parainfluenza, diarrheal vaccines, herpesvirus, shigella, malaria, chlamydia, syphillis, rabies, toxoplasmosis, lyme disease, human papilloma virus, dengue, encephalitis, respiratory syncytial virus, pneumococcus, streptococcus and helicobacter pylori; anaesthetics, topical anaesthetics; narcotic analgesics and analgesics; anti-hypertensives and anti-anginals; preparations for the prophylaxis and treatment of asthma; dermatological preparations; topical creams for the treatment of skin disorders; laxatives; preparations for the treatment of respiratory diseases; preparations for the treatment of sinusitis, bronchitis, pharyngitis and rhinitis; cold treatments; cough treatments; influenza treatments; expectorants, decongestants and cough suppressants; antipyretics; antihistamines; preparations for the treatment of allergies; preparations for the treatment of heart disease; anti-diarrhoea preparations; preparations for the treatment of obesity; preparations for the treatment of hyperactivity; preparations for the treatment of narcolepsy; preparations for the treatment of cancer, thrombosis and upper gastrointestinal bleeding; preparations for the treatment of gastrointestinal disorders; preparations for the treatment of edema; recombinant hormones for tissue remodelling; recombinant DNA for gene therapy of single gene disorders, corticosteroids for use in treating endocrine disorders, rheumatic disorders, dermatologic diseases, allergic states, ophthalmic diseases, respiratory diseases, hemotologic disorders, neoplastic diseases, edematous states, gastrointestinal diseases, nervous system disorders, tuberculous meningitis, tuberculosis and trichinosis; preparations for the treatment of mastocytosis; inhalers, metered dose inhalers, dry powder inhalers, pharmaceutical containers for use in inhalers, all filled with pharmaceutical preparations and substances for use in the treatment of bronchial asthma and for treating respiratory illness and disorders Medical devices namely, injection instruments; syringes; hypodermic syringes; injectors for medical purposes; needles for medical purposes; infusion devices; inhalers; metered dose inhalers; dry powder inhalers, all of the foregoing sold empty

Mark Description:

N/A

Class:

Surgical

Type of Mark:

Trademark

Published for Opposition Date:

07-23-2002

Mark Drawing Status:

Design plus Words, Letters, and/or Numbers

Abandon Date:

N/A

Business Name:

BACON & THOMAS , PLLC

Correspondent Name:

Recent Trademark filings by this company